

The development of novel tissue-equivalent materials at the University of Surrey might open the way for a new generation of flexible X-ray detectors, with possible uses ranging from cancer therapy to improved airport scanners.
X-ray detectors have traditionally been composed of heavy, rigid materials such as silicon or germanium. New, flexible detectors are less expensive and can be molded to scan things, boosting accuracy when screening patients and lowering danger when imaging tumors and giving radiotherapy.
Dr Prabodhi Nanayakkara, who led the research at the University of Surrey, said:
“This new material is flexible, low-cost, and sensitive. But what’s exciting is that this material is tissue equivalent. This paves the way for live dosimetry, which just isn’t possible with current technology.”
Professor Ravi Silva, director of Surrey’s Advanced Technology Institute, said:
“This new technology could be used in a variety of settings, such as radiotherapy, scanning historical artefacts and in security scanners. The University of Surrey together with its spin out SilverRay Ltd continues to lead the way in flexible X-ray detectors – we’re pleased to see the technology shows real promise for a range of uses.”
Co-author, Professor Martin Heeney, Imperial College London, commented:
“We have been developing heavy analogues of traditional organic semiconductors for some time, and we were intrigued when Dr Imalka Jayawardena suggested their application in X-ray detectors. These results are very exciting, especially considering this was the first material investigated, and there is plenty of scope for further improvements.”
For more information: University of Surrey
more recommended stories
HEALEY Platform Accelerates ALS Therapy Research
A New Era of ALS Clinical.
Low-Oxygen Therapy in a HypoxyStat Pill? Scientists Say It’s Possible
A New Approach to Oxygen Regulation-HypoxyStat.
Early Alzheimer’s Diagnosis with Advanced Tau Test
A New Biomarker Test Promises Early.
AI and 3D Printing Unlock New Neuron Growth Insights
3D-Printing Brain Model Unlocks Neuron Growth.
AI Uncovers Hidden Pregnancy Risks for Stillbirth
A groundbreaking AI-driven study has identified.
Harvard Study Unveils New TB Drug Regimens
A Harvard Medical School-led clinical trial.
Affordable AI Tool Predicts Cancer Immunotherapy Outcomes
Researchers from Memorial Sloan Kettering Cancer.
Inogen’s SIMEOX 200 Gets FDA Clearance for Airway Care
Inogen, Inc., a medical technology company.
AI System Tracks Emerging infectious Disease
Researchers have developed a novel method.
Psilocybin Helps Reduce Anxiety, Depression During Cancer
Groundbreaking research from NYU Langone Health.
Leave a Comment